are there any oral glp 1 drugs GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Oral GLP-1s rapidly expanding user

If you develop autoimmune thyroid problems, they need to be treated

When you dont have enough in your body, it suffers from oxidative stress caused by free radicals

For patients, these cost saving measures can feel frustrating and counterproductive

Putative role of adipose tissue in growth andmetabolism of colon cancer cells

Presentation Details Poster Title: Efsubaglutide Alfa in Overweight or Obesity: Phase IIb ENLIGHT Study Abstract Number: 2636-P Presentation Time: June 8, 2026, 12:30 PM (Central Time) Presenter: Qinghua Wang, Ph.D., Founder, Chairman and Chief Executive Officer of Innogen Innogen's proprietary Efsubaglutide met the primary endpoint of the Phase IIb ENLIGHT study conducted in Chinese overweight and obese adults